查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1561447

2024-2032 年放射治疗市场报告（按类型、应用、最终用户和地区）

Radiotherapy Market Report by Type, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3个工作天内

价格

2023年全球放射治疗IMARC Group规模达68亿美元。癌症发病率的上升、技术的进步、肿瘤靶向精度的提高、医疗保健支出的增加以及对放射治疗作为非侵入性癌症治疗选择的益处的认识的提高，是为市场增长创造积极前景的一些因素。

放射治疗市场分析：

  • 主要市场驱动因素：放射治疗市场主要是由全球癌症发生率上升所推动的，这创造了对非侵入性、高效治疗方案的需求。除此之外，发展中地区医疗保健支出的增加和医疗保健基础设施的改善（更容易获得先进的放射治疗）正在提振放射治疗的需求。
  • 主要市场趋势：放射治疗设备的技术进步，例如调强放射治疗（IMRT）和影像导引放射治疗（IGRT）的发展，代表了放射治疗市场的主要趋势之一。同时，人工智慧（AI）在放射治疗中的整合改善了治疗计划和实施是另一个新兴趋势，导致更个人化和有效的癌症护理。
  • 地理趋势：放射治疗市场预测显示，北美因其先进的医疗基础设施、高医疗支出和较早采用新技术而成为主导地区。该地区强大的监管框架和对癌症研究的大量投资也有助于其领先地位。此外，在医疗保健意识提高、癌症盛行率上升和医疗设施改善的推动下，亚太地区正在经历快速增长。
  • 竞争格局：一些主要的放射治疗公司包括 Accuray Incorporated、Becton Dickinson and Company、Eckert & Ziegler、Elekta AB (publ)、General Electric Company、Hitachi Ltd、Ion Beam Applications、Isoray Inc.、Mevion Medical Systems Inc.、Nordion Inc. (Sotera Health) 和西门子Healthineers AG (Siemens AG) 等。
  • 挑战与机会：根据放射治疗市场概况，放射治疗系统和治疗的高成本可能令许多患者和医疗保健系统望而却步，这是市场成长的主要限制因素。然而，这项挑战为放射治疗市场提供了开发具有成本效益的治疗模式和引入更合理技术的新机会。同时，在发展中市场扩大对临床医生的培训和教育，以确保安全有效地使用先进的放射治疗技术，正在对放射治疗市场前景产生积极影响。

放射治疗市场趋势：

技术进步

放射治疗市场的最新发展和创新，如调强放射治疗（IMRT）和影像导引放射治疗（IGRT），大大提高了癌症治疗的精确度和有效性，有助于市场扩张。 IGRT 涉及在放射治疗过程中使用即时成像，确保肿瘤被准确瞄准，即使治疗之间存在移动。这使得肿瘤学家能够在治疗期间透过改变光束强度来调节辐射剂量，有效地使辐射剂量符合肿瘤的形状，同时最大限度地减少对周围健康组织的暴露。此外，2020年4月，国际原子能机构启动了一个项目，研究立体定位放射治疗（SFRT）如何增强肺癌和子宫颈癌的安宁疗护，旨在减轻症状并减缓疾病进展，这进一步有助于市场扩张。

人工智慧（AI）在放射治疗中的整合

人工智慧技术被用来简化规划流程、提高辐射剂量的准确性并优化治疗计划。机器学习 (ML) 演算法可以分析成像和治疗记录的大型资料集，以识别模式并预测针对个别患者量身定制的最佳治疗方法。人工智慧也被用来开发患者对各种放射治疗反应的预测模型，该模型可用于适应性放射治疗，根据患者对正在进行的治疗的反应来调整治疗。放射科医生在 40 年内查看大约 225,000 次 MRI/CT 检查，而人工智慧可以从 225,000 次扫描开始进行自我训练，并在很短的时间内达到数百万次扫描。这将简化营运并将医疗保健服务扩展到更多人群，从而增加放射治疗市场收入。

转向个人化医疗

癌症治疗对个人化医疗的日益转变正在日益影响放射治疗市场。个人化医疗方法涉及根据每个患者的个别特征量身定制医疗治疗，在放射治疗的背景下，这意味着根据可能影响治疗反应的遗传、表型和环境因素量身定制放射剂量和时间表。医疗保健提供者可以透过专注于个人化患者护理来减少不良副作用的发生率并提高治疗效果。个人化医疗联盟的报告显示，2016年至2020年间，美国市场的个人化药物数量增加了一倍。年的成长率为5%。

放射治疗市场细分：

IMARC Group提供了每个细分市场的主要趋势分析，以及 2024-2032 年全球、区域和国家层面的预测。我们的报告根据类型、应用程式和最终用户对市场进行了分类。

按类型划分：

  • 外束放射治疗
    • 调强放射治疗 (IMRT)
    • 影像导引放射治疗 (IGRT)
    • 断层放射治疗
    • 立体定位放射外科
    • 立体定位放射治疗
    • 质子治疗
    • 3D 适形放射治疗 (3D CRT)
    • 容积调製电弧疗法 (VMAT)
  • 内部放射治疗/近距离放射治疗
  • 全身放射治疗

外照射放射治疗占大部分市场份额

该报告根据类型提供了详细的市场细分和分析。这包括外束放射治疗（调强放射治疗(IMRT)、影像导引放射治疗(IGRT)、断层放射治疗、立体定位放射手术、立体定位身体放射治疗、质子治疗、3D 适形放射治疗(3D CRT)和体积调製弧治疗（VMAT））、内部放射治疗/近距离放射治疗和全身放射治疗。根据该报告，体外放射治疗占最大部分。

根据放射治疗市场分析，体外放射治疗（EBRT）的多功能性和精确治疗多种癌症的有效性推动了其需求的激增。与此一致的是，EBRT 仍然是最常见的放射治疗形式，因为它能够精确地以高能量束瞄准肿瘤，最大限度地减少对周围健康组织的损害。此外，三维（3D）适形放射治疗、调强放射治疗（IMRT）和立体定位放射治疗（SBRT）等技术先进系统的引入，大大增强了EBRT的吸引力，创造了积极的市场前景扩张。

按应用划分：

  • 皮肤癌和唇癌
  • 头颈癌
  • 乳癌
  • 摄护腺癌
  • 子宫颈癌
  • 肺癌
  • 其他的

乳癌占产业最大份额

报告还提供了基于应用程式的详细市场细分和分析。这包括皮肤癌和唇癌、头颈癌、乳癌、摄护腺癌、子宫颈癌、肺癌等。报告称，乳癌占最大的市场份额。

放射治疗作为预防乳癌肿瘤復发的标准术后治疗策略的功效是推动其市场需求的关键因素。根据世界卫生组织(WHO) 统计，到2022 年，全球有230 万名女性被诊断出罹患乳癌，67 万人死亡。全球乳癌发生率不断上升，需要有效的治疗方式，而放射治疗因其在早期和晚期乳癌中的关键作用而得到认可。它对于早期乳癌的保存乳房特别有效，通常在肿瘤切除术后使用，以消除任何残留的癌细胞并显着降低癌症復发的风险。此外，放射治疗还有助于缓解晚期转移病例的症状并控制肿瘤生长，这进一步增加了其需求。

按最终用户划分：

  • 医院
  • 癌症研究机构
  • 门诊及放射治疗中心

门诊和放射治疗中心代表了领先的细分市场

该报告提供了基于最终用户的详细市场细分和分析。这包括医院、癌症研究机构以及门诊和放射治疗中心。根据该报告，门诊和放射治疗中心占最大部分。

根据放射治疗市场报告，门诊和放射治疗中心的需求是由对门诊护理环境的日益偏好所推动的，与住院治疗相比，门诊护理环境提供成本效益、便利性并减轻患者负担。门诊护理中心特别有吸引力，因为它们使患者能够接受高品质的专业护理，而无需住院过夜。此外，由于这些中心在管理放射治疗等特定治疗方面的专业和效率，通常可以比传统医院环境以更低的成本提供服务。这种成本效益吸引了寻求管理支出的患者和医疗保健付款人。此外，放射治疗中心的激增和技术进步使复杂的放射治疗设备变得更加紧凑和负担得起，正在推动市场向前发展。

按地区划分：

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

北美市场处于领先地位，占据最大的放射治疗市场。

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美是放射治疗最大的区域市场。

北美对放射治疗的需求受到多种因素的推动，例如完善的医疗基础设施、癌症研究的雄厚资金以及癌症的高盛行率。北美拥有一些世界领先的癌症研究机构和医院，它们采用并开发了尖端的放射治疗技术。除此之外，该地区还受益于公共和私营部门的大量医疗保健支出，从而可以对先进医疗设备和治疗方式进行大量投资。此外，人们非常关注早期癌症检测和筛检计划，该计划确定可以从放射治疗早期干预中受益的患者，这正在推动市场成长。

（请注意，这只是关键参与者的部分列表，报告中提供了完整列表。）

  • 竞争格局的特征是知名放射治疗公司的存在，它们透过技术创新、併购、拓展新兴市场等方式进行激烈竞争。他们正在开发具有更高精度和适应性的先进放射治疗系统，并利用其广泛的技术组合和强大的全球影响力来提高市场份额并渗透到新的地理区域。此外，专业公司还分别专注于近距离放射治疗和紧凑型质子治疗系统等利基技术，以提供满足特定临床需求并在市场上获得竞争优势的客製化解决方案。

放射治疗市场新闻：

  • 2022 年 5 月，Elekta AB 推出了 Elekta Espirit，这是一款下一代伽玛刀，可实现更个人化的放射外科手术。
  • 2023年5月，通用电气公司推出了多种放射治疗仪器，包括自动分割、智慧放射治疗（IRT）和更新的MR放射治疗套件。
  • 2023 年 9 月，西门子 Healthineers 收购了 Aspekt，以加强其放射肿瘤学服务。

本报告回答的关键问题：

  • 迄今为止，全球放射治疗市场表现如何，未来几年将如何表现？
  • 全球放射治疗市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球放射治疗市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的放射治疗市场？
  • 依类型划分市场是怎么样的？
  • 放疗市场上哪种类型最有吸引力？
  • 基于应用的市场区隔是什么？
  • 放射治疗市场中哪一个应用最具吸引力？
  • 基于最终用户的市场区隔是什么？
  • 放疗市场上哪一个最有吸引力的最终用户？
  • 市场竞争结构如何？
  • 谁是全球放射治疗市场的主要参与者/公司

本报告回答的关键问题：

  • 迄今为止，全球放射治疗市场表现如何，未来几年将如何表现？
  • 全球放射治疗市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球放射治疗市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的放射治疗市场？
  • 依类型划分市场是怎么样的？
  • 放疗市场上哪种类型最有吸引力？
  • 基于应用的市场区隔是什么？
  • 放射治疗市场中哪一个应用最具吸引力？
  • 基于最终用户的市场区隔是什么？
  • 放疗市场上哪一个最有吸引力的最终用户？
  • 市场竞争结构如何？
  • 谁是全球放射治疗市场的主要参与者/公司

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球放射治疗市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 外束放射治疗
    • 市场趋势
    • 关键环节
      • 调强放射治疗 (IMRT)
      • 影像导引放射治疗 (IGRT)
      • 断层放射治疗
      • 立体定位放射外科
      • 立体定位放射治疗
      • 质子治疗
      • 3D 适形放射治疗 (3D CRT)
      • 容积调製电弧疗法 (VMAT)
    • 市场预测
  • 内部放射治疗/近距离放射治疗
    • 市场趋势
    • 市场预测
  • 全身放射治疗
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按应用

  • 皮肤癌和唇癌
    • 市场趋势
    • 市场预测
  • 头颈癌
    • 市场趋势
    • 市场预测
  • 乳癌
    • 市场趋势
    • 市场预测
  • 摄护腺癌
    • 市场趋势
    • 市场预测
  • 子宫颈癌
    • 市场趋势
    • 市场预测
  • 肺癌
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 医院
    • 市场趋势
    • 市场预测
  • 癌症研究机构
    • 市场趋势
    • 市场预测
  • 门诊及放射治疗中心
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Accuray Incorporated
    • Becton Dickinson and Company
    • Eckert & Ziegler
    • Elekta AB (publ)
    • General Electric Company
    • Hitachi Ltd
    • Ion Beam Applications
    • Isoray Inc.
    • Mevion Medical Systems Inc.
    • Nordion Inc. (Sotera Health)
    • Siemens Healthineers AG (Siemens AG)
Product Code: SR112024A4413

The global radiotherapy market size reached US$ 6.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.7 Billion by 2032, exhibiting a growth rate (CAGR) of 3.9% during 2024-2032. The rise in cancer incidence, advancements in technology, increasing precision in tumor targeting, growing healthcare expenditure, and heightened awareness of radiotherapy's benefits as a non-invasive cancer treatment option are some of the factors creating a positive outlook for the market growth.

Radiotherapy Market Analysis:

  • Major Market Drivers: The market for radiotherapy is primarily driven by the rising incidence of cancer worldwide, which is creating a demand for non-invasive, efficient treatment options. Besides this, the increased healthcare spending and improvements in healthcare infrastructure in the developing region, where access to advanced radiation treatments is more available, are bolstering the radiotherapy demand.
  • Key Market Trends: Technological advancements in radiotherapy devices, such as the development of intensity-modulated radiotherapy (IMRT) and image-guided radiotherapy (IGRT), represent one of the major radiotherapy market trends. Concurrently, the integration of artificial intelligence (AI) in radiotherapy improving treatment planning and delivery is another emerging trend leading to more personalized and effective cancer care.
  • Geographical Trends: The radiotherapy market forecast revealed North America as the dominating region due to its advanced healthcare infrastructure, high healthcare expenditure, and early adoption of new technologies. The region's strong regulatory framework and substantial investments in cancer research also contribute to its leading position. Furthermore, Asia Pacific is experiencing rapid growth, driven by increasing healthcare awareness, rising cancer prevalence, and improving healthcare facilities.
  • Competitive Landscape: Some of the major radiotherapy companies are Accuray Incorporated, Becton Dickinson and Company, Eckert & Ziegler, Elekta AB (publ), General Electric Company, Hitachi Ltd, Ion Beam Applications, Isoray Inc., Mevion Medical Systems Inc., Nordion Inc. (Sotera Health) and Siemens Healthineers AG (Siemens AG) among many others.
  • Challenges and Opportunities: According to the radiotherapy market overview, the high cost of radiotherapy systems and treatments, which can be prohibitive for many patients and healthcare systems, is a major constraint for the market growth. However, this challenge presents the radiotherapy market with recent opportunities for the development of cost-effective treatment models and the introduction of more reasonable technology. Along with this, the expansion of training and education for clinicians in developing markets to ensure the safe and effective use of advanced radiotherapy technologies is positively impacting the radiotherapy market outlook.

Radiotherapy Market Trends:

Technological advancements

Radiotherapy market recent developments and innovations such as intensity-modulated radiotherapy (IMRT) and image-guided radiotherapy (IGRT) have greatly improved the precision and effectiveness of cancer treatments, aiding in market expansion. IGRT involves the use of real-time imaging during radiation therapy sessions, ensuring that the tumor is accurately targeted, even if there is movement between treatments. This allows oncologists to modulate the radiation dose by varying the beam intensity during treatment, effectively conforming the radiation dose to the shape of the tumor while minimizing exposure to surrounding healthy tissues. Moreover, in April 2020, the IAEA started a project to study how Stereotactic Fractionated Radiotherapy (SFRT) can enhance palliative treatment for lung and cervical cancers, aiming to alleviate symptoms and slow down disease progression, which is further aiding in market expansion.

Integration of artificial intelligence (AI) in radiotherapy

AI technologies are being used to streamline the planning process, improve the accuracy of radiation dosing, and optimize treatment schedules. Machine learning (ML) algorithms can analyze large datasets of imaging and treatment records to identify patterns and predict optimal treatment approaches tailored to individual patients. AI is also being utilized to develop predictive models for patient responses to various radiation therapies, which can be used in adaptive radiotherapy to adjust treatments based on the patient's response to ongoing sessions. Radiologists look at approximately 225,000 MRI/CT exams in 40 years, while AI can start with 225,000 scans to train itself and reach millions of scans within a very short period of time. This will streamline operations and expand healthcare services to a larger population, thereby boosting radiotherapy market revenue.

Shift toward personalized medicine

The growing shift towards personalized medicine in cancer treatment is increasingly influencing the radiotherapy market. Personalized medicine approaches involve tailoring medical treatment to the individual characteristics of each patient, and in the context of radiotherapy, this means customizing radiation doses and schedules based on genetic, phenotypic, and environmental factors that could affect treatment response. Healthcare providers can reduce the incidence of unfavorable side effects and increase treatment efficacy by concentrating on individualized patient care. The Personalized Medicine Coalition's report indicates that the number of personalized medicines in the US market doubled between 2016 and 2020. These medicines, which accounted for 25% of new drugs approved by the FDA in 2019, rose from 132 to 286, marking a significant increase from 5% in 2005. This growth is boosting the radiotherapy market share.

Radiotherapy Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, application, and end user.

Breakup by Type:

  • External Beam Radiation Therapy
    • Intensity-Modulated Radiation Therapy (IMRT)
    • Image-Guided Radiation Therapy (IGRT)
    • Tomotherapy
    • Stereotactic Radiosurgery
    • Stereotactic Body Radiation Therapy
    • Proton Therapy
    • 3D Conformal Radiotherapy (3D CRT)
    • Volumetric Modulated Arc Therapy (VMAT)
  • Internal Radiation Therapy/Brachytherapy
  • Systemic Radiation Therapy

External beam radiation therapy accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the type. This includes external beam radiation therapy (intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), tomotherapy, stereotactic radiosurgery, stereotactic body radiation therapy, proton therapy, 3D conformal radiotherapy (3D CRT), and volumetric modulated arc therapy (VMAT)), internal radiation therapy/brachytherapy and systemic radiation therapy. According to the report, external beam radiation therapy represented the largest segment.

Based on the radiotherapy market analysis, the surging demand for external beam radiation therapy (EBRT) is driven by its versatility and effectiveness in treating a wide range of cancers with precision. In line with this, EBRT remains the most common form of radiotherapy due to its ability to accurately target tumors with high-energy beams, minimizing damage to surrounding healthy tissues. Furthermore, the introduction of technologically advanced systems like three-dimensional (3D) conformal radiation therapy, intensity-modulated radiation therapy (IMRT), and stereotactic body radiation therapy (SBRT) has greatly enhanced the appeal of EBRT, creating a positive outlook for market expansion.

Breakup by Application:

  • Skin and Lip Cancer
  • Head and Neck Cancer
  • Breast Cancer
  • Prostate Cancer
  • Cervical Cancer
  • Lung Cancer
  • Others

Breast cancer holds the largest share of the industry

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes skin and lip cancer, head and neck cancer, breast cancer, prostate cancer, cervical cancer, lung cancer, and others. According to the report, breast cancer accounted for the largest market share.

Radiotherapy's efficacy as a standard post-operative therapeutic strategy to prevent tumor recurrence in breast cancer represents a crucial factor driving its market demand. According to the World Health Organization (WHO), there were 2.3 million women diagnosed with breast cancer and 670,000 deaths globally in 2022. This increasing incidence of breast cancer globally necessitates effective treatment modalities, and radiotherapy is recognized for its critical role in the early and advanced stages of the disease. It is particularly effective in conserving the breast in cases of early-stage breast cancer, often used following lumpectomy to eliminate any remaining cancerous cells and significantly reduce the risk of cancer returning. Additionally, radiotherapy also helps alleviate symptoms and control tumor growth in advanced metastatic cases, which is further boosting its demand.

Breakup by End User:

  • Hospitals
  • Cancer Research Institutes
  • Ambulatory and Radiotherapy Centers

Ambulatory and radiotherapy centers represent the leading market segment

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, cancer research institutes, and ambulatory and radiotherapy centers. According to the report, ambulatory and radiotherapy centers represented the largest segment.

As per the radiotherapy market report, its demand in ambulatory and radiotherapy centers is driven by an increasing preference for outpatient care settings, which offer cost-efficiency, convenience, and reduced patient burden compared to in-hospital treatments. Ambulatory care centers are particularly appealing because they enable patients to receive high-quality, specialized care without the need for overnight hospital stays. Additionally, these centers can often provide services at a lower cost than traditional hospital settings due to their specialized nature and efficiency in managing specific treatments like radiotherapy. This cost-effectiveness attracts patients and healthcare payers seeking to manage expenditures. Furthermore, the proliferation of radiotherapy centers and technological advancements that make sophisticated radiotherapy equipment more compact and affordable, are propelling the market forward.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest radiotherapy market share.

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for radiotherapy.

The demand for radiotherapy in North America is propelled by numerous factors such as well-established healthcare infrastructure, robust funding for cancer research, and the high prevalence of cancer. North America boosts some of the world's leading cancer research facilities and hospitals, which adopt and also develop cutting-edge radiotherapy technologies. In addition to this, the region benefits from substantial healthcare spending both from the public and private sectors, allowing for significant investments in advanced medical equipment and treatment modalities. Furthermore, there is a strong focus on early cancer detection and screening programs, which identify patients who can benefit from early intervention using radiotherapy, which is impelling the market growth.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the radiotherapy industry include Accuray Incorporated, Becton Dickinson and Company, Eckert & Ziegler, Elekta AB (publ), General Electric Company, Hitachi Ltd, Ion Beam Applications, Isoray Inc., Mevion Medical Systems Inc., Nordion Inc. (Sotera Health), Siemens Healthineers AG (Siemens AG), etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • The competitive landscape is characterized by the presence of prominent radiotherapy companies who are engaged in fierce competition through technological innovation, mergers, and acquisitions, and expansion into emerging markets. They are developing advanced radiotherapy systems with enhanced precision and adaptability and leveraging their broad technological portfolios and strong global presence to enhance their market share and penetrate new geographical regions. Additionally, specialized companies are focusing on niche technologies like brachytherapy and compact proton therapy systems, respectively to offer tailored solutions that meet specific clinical needs and gain a competitive edge in the market.

Radiotherapy Market News:

  • In May 2022, Elekta AB launched Elekta Espirit, a next-generation gamma knife that enables more personalized radiosurgery.
  • In May 2023, General Electric Company launched multiple radiotherapy instruments, including auto segmentation, intelligent radiation therapy (IRT), and an updated MR radiation therapy suite.
  • In September 2023, Siemens Healthineers acquired Aspekt to strengthen its radiation oncology services.

Key Questions Answered in This Report:

  • How has the global radiotherapy market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global radiotherapy market?
  • What is the impact of each driver, restraint, and opportunity on the global radiotherapy market?
  • What are the key regional markets?
  • Which countries represent the most attractive radiotherapy market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the radiotherapy market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the radiotherapy market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the radiotherapy market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global radiotherapy market

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Radiotherapy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 External Beam Radiation Therapy
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Intensity-Modulated Radiation Therapy (IMRT)
      • 6.1.2.2 Image-Guided Radiation Therapy (IGRT)
      • 6.1.2.3 Tomotherapy
      • 6.1.2.4 Stereotactic Radiosurgery
      • 6.1.2.5 Stereotactic Body Radiation Therapy
      • 6.1.2.6 Proton Therapy
      • 6.1.2.7 3D Conformal Radiotherapy (3D CRT)
      • 6.1.2.8 Volumetric Modulated Arc Therapy (VMAT)
    • 6.1.3 Market Forecast
  • 6.2 Internal Radiation Therapy/Brachytherapy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Systemic Radiation Therapy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Skin and Lip Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Head and Neck Cancer
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Breast Cancer
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Prostate Cancer
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Cervical Cancer
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Lung Cancer
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cancer Research Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory and Radiotherapy Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Accuray Incorporated
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Eckert & Ziegler
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Elekta AB (publ)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 General Electric Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Hitachi Ltd
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Ion Beam Applications
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Isoray Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Mevion Medical Systems Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Nordion Inc. (Sotera Health)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 SWOT Analysis
    • 14.3.11 Siemens Healthineers AG (Siemens AG)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Radiotherapy Market: Major Drivers and Challenges
  • Figure 2: Global: Radiotherapy Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Radiotherapy Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Radiotherapy Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Radiotherapy Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Radiotherapy Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Radiotherapy Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Radiotherapy (External Beam Radiation Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Radiotherapy (External Beam Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Radiotherapy (Internal Radiation Therapy/Brachytherapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Radiotherapy (Internal Radiation Therapy/Brachytherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Radiotherapy (Systemic Radiation Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Radiotherapy (Systemic Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Radiotherapy (Skin and Lip Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Radiotherapy (Skin and Lip Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Radiotherapy (Head and Neck Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Radiotherapy (Head and Neck Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Radiotherapy (Breast Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Radiotherapy (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Radiotherapy (Prostate Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Radiotherapy (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Radiotherapy (Cervical Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Radiotherapy (Cervical Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Radiotherapy (Lung Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Radiotherapy (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Radiotherapy (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Radiotherapy (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Radiotherapy (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Radiotherapy (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Radiotherapy (Cancer Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Radiotherapy (Cancer Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Radiotherapy (Ambulatory and Radiotherapy Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Radiotherapy (Ambulatory and Radiotherapy Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: North America: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: North America: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: United States: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: United States: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Canada: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Canada: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Asia-Pacific: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Asia-Pacific: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: China: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: China: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Japan: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Japan: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: India: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: India: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: South Korea: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: South Korea: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Australia: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Australia: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Indonesia: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Indonesia: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Others: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Others: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Europe: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Europe: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Germany: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Germany: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: France: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: France: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: United Kingdom: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: United Kingdom: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Italy: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Italy: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Spain: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Spain: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Russia: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Russia: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Latin America: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Latin America: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Brazil: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Brazil: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Mexico: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Mexico: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Others: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Others: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Middle East and Africa: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Middle East and Africa: Radiotherapy Market: Breakup by Country (in %), 2023
  • Figure 82: Middle East and Africa: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Global: Radiotherapy Industry: SWOT Analysis
  • Figure 84: Global: Radiotherapy Industry: Value Chain Analysis
  • Figure 85: Global: Radiotherapy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Radiotherapy Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Radiotherapy Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Radiotherapy Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Radiotherapy Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Radiotherapy Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Radiotherapy Market: Competitive Structure
  • Table 7: Global: Radiotherapy Market: Key Players